title: [Relationship between the antileukemic activity of L-asparaginase and Asn level around leukemic cells].
abstract: OBJECTIVE
  To study the antileukemic activity of L-asparaginase through determining the changes of 4 kinds of amino acids (Asn, Aspa, Glu and Gln) in cell culture medium.
  
  
  METHODS
  Following L-Asp treatment with designed concentrations and duration, the IC50 (inhibitory concentration 50%) of 8 kinds of common leukemia cell lines (U937, HL-60, Jurkat, NB4, THP-1, Namalwa, Karpass299, K562) were determined by CCK-8 assay. The changes of the 4 kinds of amino acids mentioned above were detected by high performance liquid chromatography (HPLC).
  
  
  RESULTS
  The asparagines in cell culture medium were rapidly exhausted when treated with 0.01 U/mL L-Asp for 4 hrs or 1 U/mL L-Asp for 5 minutes. There were significant differences in the sensitivities to L-Asp of different leukemia cell lines. The sensitivities to L-Asp of various cell lines were dose-dependent. Low concentration of L-Asp resulted in a low IC50 and the IC50 increased following the L-Asp concentration increased.
  
  
  CONCLUSIONS
  Different leukemia cell lines have different sensitivities to L-Asp, suggesting that exhaustion of asparagines around leukemia cells could not reflect the treatment efficacy of L-Asp. L-Asp antileukemic activity is dose-dependent, which suggests the importance of high-dose L-Asp on childhood acute lymphoblastic leukemia.
authors.affiliation: Department of Hematology, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China.
authors.forename: Ben-Shang
authors.initials: BS
authors.lastname: Li
authors.forename: Chang-Ying
authors.initials: CY
authors.lastname: Luo
authors.forename: Ying-Yi
authors.initials: YY
authors.lastname: He
authors.forename: Hua
authors.initials: H
authors.lastname: Jiang
authors.forename: Long-Jun
authors.initials: LJ
authors.lastname: Gu
mesh_terms: D001215:Asparaginase / Q000494:pharmacology*; D001216:Asparagine / Q000032:analysis*; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy
chemical_list: D001216:Asparagine; D001215:Asparaginase